Tag: end stage renal disease (esrd)

US Kidney Transplants Grow in Number and Success

Kidney transplantation has recently been happening at a record pace and with unprecedented success despite patients having more risk factors than ever before. During 2016-2019,...

Chronic Kidney Disease Tied to Worse LAAO Outcomes

The presence of chronic kidney disease (CKD) or end-stage renal disease (ESRD) is associated with worse in-hospital and short-term outcomes after left atrial appendage (LAA)...

Artificial Pancreas Tried in Type 2 Diabetes Patients on Dialysis

A fully closed-loop artificial pancreas system improved glucose control and reduced hypoglycemia compared with standard insulin therapy in adult outpatients with type 2 diabetes requiring...

Kidney Transplant Outcomes Good in Undocumented Immigrants

Undocumented immigrants with end-stage renal disease who underwent kidney transplantation had outcomes that were as good as, if not better than, those in the general...

Dapagliflozin Safe, Protective in Advanced Kidney Disease

Patients with stage 4 chronic kidney disease (CKD) who were in the DAPA-CKD trial had cardiorenal benefits from dapagliflozin that were similar to those of...

Prominent Nephrologist, Mount Sinai Chair of Medicine Dies

Dr Barbara T. Murphy Barbara T. Murphy, MD, renowned nephrologist and professor of medicine at Mount Sinai School of Medicine in New York City, has...

Hypomethylating Agents in Children With Relapsed/Refractory AML

Hypomethylating agents are generally considered to be agents of choice for older adults with acute myeloid leukemia who cannot tolerate the rigors of more intensive...

New Transplant Policy Doesn’t Benefit All States

The introduction of the new kidney allocation policy in the US initiated by the Organ Procurement and Transplantation Network (OPTN) may not benefit all states...

Pharmacist + App Cuts Errors, Hospitalization After Transplant

A pharmacist-led intervention that involves use of a smartphone app with home monitoring significantly reduced medication errors, adverse events, and hospitalizations among kidney transplant patients,...

New Test Could Help Primary Care Docs Chart Kidney Disease

A novel test that estimates the risk of a patient with type 2 diabetes developing end-stage kidney disease significantly outperformed more conventional risk-prediction methods in...

Task Force Reviewing Race Modifier in eGFR Issues Interim Report

The race coefficient now used in calculating estimated glomerular filtration rate (eGFR) in US patients who self-identify as Black will soon change, says a task...

Difelikefalin Safe, Effective for Kidney Disease-Associated Pruritus

Difelikefalin, an investigational intravenous (IV) drug for treating itch (pruritus) in patients with end-stage renal disease on hemodialysis, was safe and effective in two parallel...

Troubling Trends for Infective Endocarditis in Dialysis Patients

The occurrence of endocarditis in hemodialysis patients may be significantly higher than previously thought, but it is as lethal as ever, a new observational study...

‘Major Update’ of BP Guidance for Kidney Disease

The new 2021 Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for blood pressure management for adults with chronic kidney disease (CKD) who are...

Blood Test Predicts Organ Rejection Risk After Kidney Transplant

A functional immunologic assay that could easily be incorporated into routine laboratory work can predict which patients are at high risk for rejection of their...

Springboard Needed to Boost Access to Living Donor Kidney Transplants

A new study indicates numerous ways in which transplant teams can try to reduce disparities that currently mean that Black patients are far less likely...

Race Modifier Means Black Patients Miss Out on Kidney Transplants

New evidence further confirms that use of the race coefficient when calculating estimated glomerular filtration rate (eGFR) in Black patients with chronic kidney disease (CKD)...

Medicare Coverage of Kidney Transplant Drugs Is Extended

A newly passed US law ensures, starting in 2023, that for Medicare patients who receive a kidney transplant, insurance coverage of immunosuppressant drugs that prevent...

‘Kidney’ vs ‘Renal’: Experts Say Words Matter

The KDIGO consensus report for nomenclature for kidney function and disease recommends largely replacing the word “renal” with “kidney” instead, but there has been pushback,...

Decision on Race Multiplier in CKD in Blacks ‘Has Real Consequences’

Eliminating the race multiplier from calculation of the estimated glomerular filtration rate (eGFR) of more than 2000 African Americans in a Boston-based health system led...

Researchers Propose Efficiency Metrics for Living Kidney Donor Evaluations

(Reuters Health) – Certain process and outcome indicators can help measure how efficiently transplant centers evaluate living kidney donors, according to a report in the...

Death Knell for Phosphate Binders in Nondialysis CKD Patients?

The non–calcium phosphate binder lanthanum carbonate (Fosrenol) had absolutely no effect on any intermediate marker of cardiovascular (CV) risk or bone and mineral metabolism in...

TAVR and Chronic Kidney Disease: An Emerging Odd Couple

Transcatheter aortic valve replacement (TAVR) appears to stabilize or improve renal function in most patients with severe aortic stenosis and chronic kidney disease (CKD), according...

DAPA-CKD Resets eGFR Floor for Safe SGLT2 Inhibitor Use

The dramatically positive safety and efficacy results from the DAPA-CKD trial, which showed that treatment with the sodium-glucose transporter 2 (SGLT2) inhibitor dapagliflozin significantly cut...

Kidney Transplants Between HIV-Positive Individuals Yield Excellent Outcomes

NEW YORK (Reuters Health) – Kidney transplants from HIV-positive deceased donors to HIV-positive recipients yield excellent transplant and HIV outcomes, according to results from a...